banner_business banner_business

Welcome to

Arcalis India Pharmaceuticals Pvt Ltd

India’s fastest growing suer-speciality drug drivenpharmaceutical company is Arcalis India Pharmaceuticals.

A. Arcalis(India) , a pharmaceutical company, has set its sights on the chronic therapeutic segment of Nephrology, with a particular focus on Chronic Kidney Disease (CKD) patients.

B. In India, where Kidney Disease is alarmingly prevalent, Arcalis(India) faced the daunting task of addressing the growing burden and improving the lives of CKD patients.

A. With statistics revealing the staggering number of Kidney Disease cases in India, Arcalis(India)recognized the urgent need to target early-stage CKD patients.

B. Their pioneering efforts in early detection and intervention became a game-changer in tackling the disease at its initial stages, where treatment options were limited.

C. The market potential for Arcalis(India)became evident as they realized the opportunity to make a significant impact on the lives of millions of CKD patients in India.

A. Within a remarkably short span of time,Arcalis(India)made impressive strides and achieved noteworthy milestones.

B. Their commitment and dedication towards serving CKD patients led to their establishment as a leader in the Nephrology sector, specifically focusing on improving the lives of CKD patients.

C. Arcalis((ndia) widespread influence has led to a substantial increase in the number of CKD patients they cater to, highlighting their leadership position in the industry.

A. Arcalis(India) services have had a profound positive impact on CKD patients, their families, and the overall healthcare system.

B. Through innovative approaches and specialized treatments, Arcalis((India) has been able to provide tailored care, improving patients' quality of life and overall outcomes.

C. Numerous patient testimonials and success stories stand as testaments to the exceptional care provided by Arcalis(India) demonstrating their commitment to patient well-being.

A. Arcalis(India) services have had a profound positive impact on CKD patients, their families, and the overall healthcare system.

B. Through innovative approaches and specialized treatments, Arcalis((India) has been able to provide tailored care, improving patients' quality of life and overall outcomes.

C. Numerous patient testimonials and success stories stand as testaments to the exceptional care provided by Arcalis(India) demonstrating their commitment to patient well-being.

about-finbiz finbiz-small

10+

Years

Of experience in Pharmaceuticals

finbiz_service
Vision

At Arcalis(India) we work every day to grow as a leading Indian Pharma Company...

Read More
finbiz_service
Mission

Discover, Develop, Deliver: Our concise and action-oriented workflow is...

Read More
finbiz_service
Our credo

Our credo is the deeply held belief,the guiding light and the fundamental force that drives us forward every single day

Read More

Our Products

More Products
Business-solution
Sevlaneph 400 mg
Sevelamer Carbonate Tablets 400 mg
Business-solution
Sevlaneph 800 mg
Sevelamer Carbonate Tablets 800 mg
Business-solution
Meroarc 1g
Meropenem Injection I.P.
Business-solution
Myconeph S-360
Mycophenolic Acid Delayed-Release Tablets USP 360 mg
Business-solution
Tacroneph
Tacroneph Capsules IP 0.25 mg
Business_counter

18

Products

Business_counter

8

Years Of Experience

Business_counter

50

Happy Distributors

Business_counter

200

Happy Patient

Our Divisions

Nephro care

Arcalis(India), a pharmaceutical company, has set its sights on the chronic therapeutic segment of Nephrology, with a particular focus on Chronic Kidney Disease (CKD) patients.

B. In India, where Kidney Disease is alarmingly prevalent, Arcalis(India) faced the daunting task of addressing the growing burden and improving the lives of CKD patients.

Early Challenges and Market Potential

Rapid Progress and Leadership Position

Impact and Patient Care

Conclusion